Top Stocks

Quarterly Top 10 Holdings for Quarter End 31-Jan-2021

as of 29-Jan-2021

Canopy Growth Corporation 5.80%
Tilray, Inc. Com 5.49%
GW Pharmaceuticals Plc 5.34%
Innovative Industrial Properties, Inc. 5.04%
HEXO Corp Com 4.66%
Organigram Holdings Inc 4.65%
Gilead Sciences Inc. 4.42%
Scotts Miracle-Gro Comapny (The) 4.33%
Cronos Group Inc. 4.32%
Aurora Cannabis Inc. 4.32%

Top Portfolio Holdings for Quarter End 31-Jan-2021

as of 29-Jan-2021

1. Canopy Growth Corporation (CGC)
Cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands.
2. Tilray, Inc. Com (TLRY)
Cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray's sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal.
3. GW Pharmaceuticals PLC (GWPH)
GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.
4. Innovative Industrial Properties, Inc. (IIPR)
The Company is engaged in the acquisition, ownership and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities
5. HEXO Corp (HEXO)
An award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. Through its hub and spoke business strategy, HEXO Corp is partnering with Fortune 500 companies, bringing its brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to established companies, leveraging their distribution networks and capacity. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis.
6. Organigram Holdings Inc (OGI)
Focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
7. Gilead Sciences Inc. (GILD)
Develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer.
8. Scotts Miracle-Gro Company (SMG)
Hydroponics is the process of growing plants in liquids without the use of soil and is a popular method for cultivating marijuana.
9. Cronos Group Inc. (CRON)
Cultivates and sells medicinal and recreational cannabis through its medicinal brand and its two recreational brands.
10. Aurora Cannabis Inc. (ACB)
Cultivates and sells medicinal and recreational cannabis through a portfolio of brands.